Dr. Albino Copca Alvarez, MD

Dr. Copca Alvarez practices at Southern Ocean Medical Center in Manahawkin, New Jersey, part of Hackensack Meridian Health.

Dr. Copca Alvarez's NPI, 1750875050, was assigned on June 20, 2018. Dr. Copca Alvarez holds New Jersey license 25MA11237100.

Dr. Copca Alvarez's primary practice is Southern Ocean Medical Center, at 1140 Rt 72 W, Manahawkin, NJ 08050 in Ocean County. The practice phone is (609) 597-6011. Dr. Copca Alvarez also practices at Southern Ocean Medical Center, 1301 State Highway 72, Manahawkin, NJ 08050.

Dr. Copca Alvarez's primary practice is Southern Ocean Medical Center in Manahawkin, New Jersey, part of Hackensack Meridian Health. Dr. Copca Alvarez is also affiliated with Jersey Shore University Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Copca Alvarez to 2 more hospitals, 3 medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Copca Alvarez practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Copca Alvarez's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Copca Alvarez is licensed in New Jersey.

CMS data shows 98 Medicare services from Dr. Copca Alvarez across 2 procedure codes in 2024, for 107 Medicare patients. Medicare paid $15,513 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 107 Medicare patients who saw Dr. Copca Alvarez in 2024. The largest group is 75 to 84, with 38 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Copca Alvarez's median patient age at 75, with 40% women.

In 2024, Dr. Copca Alvarez wrote 31 Medicare Part D claims for 12 patients. 48% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $224 in total drug cost. In 2023, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Copca Alvarez for performance year 2024, reported as part of a group. Dr. Copca Alvarez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Copca Alvarez in 2021. Dr. Copca Alvarez's most frequent co-authors are Krishna K. Chalasani, MD, Ashali Jain and Christopher Michael Lesniak, DO.

CMS Open Payments shows 41 general payments to Dr. Copca Alvarez from 14 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 92% of the total. Philips Electronics North America Corporation paid the most, $303.